Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lipocine Inc (NASDAQ:LPCN)

9.10
Delayed Data
As of 4:00pm ET
 +0.37 / +4.24%
Today’s Change
7.00
Today|||52-Week Range
19.23
-29.62%
Year-to-Date
No recent news for Lipocine Inc.

Today’s Trading

Previous close8.73
Today’s open8.88
Day’s range8.87 - 9.30
Volume349,379
Average volume (3 months)145,553
Market cap$159.4M
Dividend yield--
Data as of 4:00pm ET, 05/24/2016

Growth & Valuation

Earnings growth (last year)+30.63%
Earnings growth (this year)-15.12%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.79

Competitors

 Today’s
change
Today’s
% change
DRRXDURECT Corp+0.04+3.45%
TBRATobira Therapeutics ...+0.15+1.78%
TKAITokai Pharmaceutical...+0.18+2.48%
MRUSMerus BV+0.15+1.50%
Data as of 4:00pm ET, 05/24/2016

Financials

Next reporting dateAugust 10, 2016
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$0.00
Annual profit (last year)-$18.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Mahesh V. Patel
CFO, Principal Accounting Officer &
EVP
Morgan R. Brown
Corporate headquarters
Salt Lake City, Utah

Forecasts

Partner Offers

Search for Jobs